Jump to content

Drilldown: Medicines

Choose a table:


Medicines > fda max: Titrated to glucose; no fixed maximum & routes: IV & halflife: ~80 minutes SC'"`UNIQ--ref-000005F2-QINU`"'

Use the filters below to narrow your results.

generic:
Insulin aspart (1)
brand:
NovoLog, Fiasp (ultra-rapid), Trurapi (1)
classes:
[[:Category:Insulins|Insulin]] (1) · [[:Category:Mealtime_insulins|Mealtime (bolus) insulin]] (1) · [[:Category:Rapid-acting_insulins|Rapid-acting insulin analog]] (1)
mechanism:
None (1)
uses:
'"`UNIQ--vote-000005EF-QINU`"', '"`UNIQ--vote-000005F0-QINU`"', '"`UNIQ--vote-000005F1-QINU`"' (1)
starting dose:
SC 4-6 units (or 1 unit per 10-15 g carbs) at meals; titrate to postprandial glucose (1)
preparations:
100 U/mL (NovoLog, Fiasp) vials, pens, cartridges (1)
fda max: (Click arrow to add another value)
routes: (Click arrow to add another value)
onset:
SC: 5-15 minutes (Fiasp 2.5 minutes earlier on average) (1)
duration:
3-5 hours (1)
halflife: (Click arrow to add another value)
bioavailability:
~100% from subcutaneous depot (1)
pregnancy:
Insulin is the preferred glucose-lowering therapy in pregnancy; aspart is widely used.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
[[USLegal:Prescription only|Rx-only]] in US (1)
Error in "where" parameter: the string "--" cannot be used within #cargo_query.

There are no results for this report.

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"